Vesicular and plasma membrane transporters for neurotransmitters

Cold Spring Harbor Perspectives in Biology

Volumn 4, Issue 2, 2012, Pages

  Blakely, Randy D ^a   Edwards, Robert H ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; NEUROTRANSMITTER TRANSPORTER;

ANIMAL; CELL MEMBRANE; EXOCYTOSIS; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW; SYNAPSE VESICLE; SYNAPTIC TRANSMISSION;

ANIMALS; CELL MEMBRANE; EXOCYTOSIS; HUMANS; NEUROTRANSMITTER AGENTS; NEUROTRANSMITTER TRANSPORT PROTEINS; SYNAPTIC TRANSMISSION; SYNAPTIC VESICLES;

EID: 84863974173     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a005595     Document Type: Article

References (250)

1. Accardi A, Miller C. 2004. Secondary active transport mediated by a prokaryotic homologue of ClC Cl-channels. Nature 427: 803-807.
2. Ahnert-Hilger G, Nurnberg B, Exner T, Schafer T, Jahn R. 1998. The heterotrimeric G protein G02 regulates catecholamine uptake by secretory vesicles. EMBO J 17: 406-413.
3. +-dependent inorganic phosphate cotransporter. J Neurochem 74: 2622-2625.
4. Albrecht J, Sonnewald U, Waagepetersen HS, Schousboe A. 2007. Glutamine in the central nervous system: Function and dysfunction. Front Biosci 12: 332-343.
5. Alfonso A, Grundahl K, Duerr JS, Han H-P, Rand JB. 1993. The Caenorhabditis elegans unc-17 gene: A putative vesicular acetylcholine transporter. Science 261: 617-619.
6. Amara SG. 1992. A tale of two families. Nature 360: 420-421.
7. Amilhon B, Lepicard E, Renoir T, Mongeau R, Popa D, Poirel O, Miot S, Gras C, Gardier AM, Gallego J, et al. 2010. VGLUT3 (vesicular glutamate transporter type 3) contribution to the regulation of serotonergic transmission and anxiety. JNeurosci 30: 2198-2210.
8. Andersen J, Taboureau O, Hansen KB, Olsen L, Egebjerg J, Stromgaard K, Kristensen AS. 2009. Location of the antidepressant binding site in the serotonin transporter: Importance ofSer-438 in recognition ofcitalopram and tricyclic antidepressants. J Biol Chem 284: 10276-10284.
9. Armano S, Coco S, Bacci A, Pravettoni E, Schenk U, Verderio Varoqui H, Erickson JD, Matteoli M. 2002. Localization and functional relevance of system a neutral amino acid transporters in cultured hippocampal neurons. J Biol Chem 277: 10467-10473.
10. Asada H, Kawamura Y, Maruyama K, Kume H, Ding RG, Kanbara N, Kuzume H, Sanbo M, Yagi T, Obata K. 1997. Cleft palate and decreased brain γ-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci 94: 6496-6499.
11. Atlante A, Passarella S, Pierro P, Di Martino C, Auagliariello E. 1996. The mechanism of proline/glutamate antiport in rat kidney mitochondria: Energy dependence and glutamate-carrier involvement. Eur J Biochemist 241: 171177.
12. Axelrod J. 1971. Noradrenaline: Fate and control of its biosynthesis. Science 173: 598-606.
13. Axelrod J. 2003. Journey of a late blooming biochemical neuroscientist. J Biol Chem 278: 1-13.
14. Axelrod J, Whitby L, Hertting G. 1961. Effect of psychotropic drugs on the uptake of3H-norepinephrine by tissues. Science 133: 383-384.
15. Baganz NL, Horton RE, Calderon AS, Owens WA, Munn JL, Watts LT, Koldzic-Zivanovic N, Jeske NA, Koek W, Toney GM, et al. 2008. Organic cation transporter 3: Keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice. Proc Natl Acad Sci 105: 18976-18981.
16. Baik HJ, Huang Y, Washington JM, Zuo Z. 2009. Critical role ofs465 in protein kinase C-increased rat glutamate transporter type 3 activity. Int J Neurosci 119: 1419-1428.
17. Bankston LA, Guidotti G. 1996. Characterization of ATP transport into chromaffin granule ghosts. Synergy of ATP and serotonin accumulation in chromaffin granule ghosts. J Biol Chem 271: 17132-17138.
18. Bauman AL, Apparsundaram S, Ramamoorthy S, Wadzinski BE, Vaughan RA, Blakely RD. 2000. Cocaine and antidepressant-sensitive biogenic amine transporters exist in regulated complexes with protein phosphatase 2A. J Neurosci 20: 7571-7578.
19. 2+-releasing channel. J Cell Biol 162: 211-222.
20. Beckman ML, Bernstein EM, Quick MW. 1998. Protein kinase C regulates the interaction between a GABA transporter and syntaxin 1A. J Neurosci 18: 6103-6112.
21. Beckstead MJ, Grandy DK, Wickman K, Williams JT. 2004. Vesicular dopamine release elicits an inhibitory postsynaptic current in midbrain dopamine neurons. Neuron 42: 939-946.
22. Bellocchio EE, Reimer RJ, Fremeau RT Jr, Edwards RH. 2000. Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter [see comments]. Science 289: 957-960.
23. Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner Heils A, Mossner R, Westphal H, Lesch KP. 1998. Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymetamphetamine ("ecstasy") in serotonin transporter-deficient mice. Mol Pharmacol 53: 649-655.
24. Bergles DE, Diamond JS, Jahr CE. 1999. Clearance of glutamate inside the synapse and beyond. Curr Opin Neurobiol 9: 293-298.
25. Bergquist F, Niazi HS, Nissbrandt H. 2002. Evidence for different exocytosis pathways in dendritic and terminal dopamine release in vivo. Brain Res 950: 245-253.
26. Binda F, Dipace C, Bowton E, Robertson SD, Lute BJ, Fog JU, Zhang M, Sen N, Colbran RJ, Gnegy ME, et al. 2008. Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux. Mol Pharmacol 74: 1101-1108.
27. Birgner C, Nordenankar K, Lundblad M, Mendez JA, Smith C, le Greves M, Galter D, Olson L, Fredriksson A, Trudeau LE, et al. 2010. VGLUT2 in dopamine neurons is required for psychostimulant-induced behavioral activation. Proc Natl Acad Sci 107: 389-394.
28. Blakely RD, DeFelice LJ, Hartzell HC. 1994. Molecular physiology of norepinephrine and serotonin transporters. J Exp Biol 196: 263-281.
29. Blakely RD, Ramamoorthy S, Schroeter S, Qian Y, Apparsundaram S, Galli A, DeFelice LJ. 1998. Regulated phosphorylation and trafficking ofantidepressant-sensitive serotonin transporter proteins. Biol Psychiatry 44: 169-178.
30. Blakely RD, DeFelice LJ, Galli A. 2005. Biogenic amine neurotransmitter transporters: Just when you thought you knew them. Physiology (Bethesda) 20: 225-231.
31. Bolan EA, Kivell B, Jaligam V, Oz M, Jayanthi LD, Han Y, Sen N, Urizar E, Gomes I, Devi LA, et al. 2007. D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism. Mol Pharmacol 71: 1222-1232.
32. Born GV, Gillson RE. 1957. The uptake of 5-hydroxytryptamine by blood platelets. J Physiol 137: 82-83.
33. Boulland JL, Qureshi T, Seal RP, Rafiki A, Gundersen V, Bergersen LH, Fremeau RT Jr, Edwards RH, Storm-Mathisen J, Chaudhry FA. 2004. Expression of the vesicular glutamate transporters during development indicates the widespread corelease of multiple neurotransmitters. J Comp Neurol 480: 264-280.
34. Bowton E, Saunders C, Erreger K, Sakrikar D, Matthies HJ, Sen N, Jessen T, Colbran RJ, Caron MG, Javitch JA, et al. Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder. J Neurosci 30: 6048-6057.
35. Broer A, Albers A, Setiawan I, Edwards RH, Chaudhry FA, Lang F, Wagner CA, Broer S. 2002. Regulation of the glutamine transporter SN1 by extracellular pH and intracellular sodium ions. J Physiol 539: 3-14.
36. Brunk I, Blex C, Rachakonda S, Holtje M, Winter S, Pahner Walther DJ, Ahnert-Hilger G. 2006. The first luminal domain of vesicular monoamine transporters mediates G-protein-dependent regulation of transmitter uptake. J Biol Chem 281: 33373-33385.
37. Busch AE, Schuster A, Waldegger S, Wagner CA, Zempel G, Broer S, Biber J, Murer H, Lang F. 1996. Expression of a renal type I sodium/phosphate transporter (NaPi-1) induces a conductance in Xenopus oocytes permeable for organic and inorganic anions. Proc Natl Acad Sci 93: 5347-5351.
38. 2+-ATP dependent storage mechanism in the amine granules of the adrenal medulla. Acta Physiol Scand 264: 7369-7376.
39. Carneiro AM, Cook EH, Murphy DL, Blakely RD. 2008. Interactions between integrin aIIb^3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans. J Clin Invest 118: 1544-1552.
40. Carroll FI, Lewin AH, Kuhar MJ. 1997. Dopamine transporter uptake blockers: Structure-activity relationships. In Neurotransmitter transporters: Structure, function, and regulation (ed. Reith MEA), pp. 263-296. Humana Press, Totowa, NJ.
41. Carvelli L, McDonald PW, Blakely RD, DeFelice LJ. 2004. Dopamine transporters depolarize neurons by a channel mechanism. Proc Natl Acad Sci 101: 16046-16051.
42. Carvelli L, Blakely RD, DeFelice LK. 2008. Dopamine transporter/syntaxin 1A interactions regulate transporter channel activity and dopaminergic synaptic transmission. Proc Natl Acad Sci 105: 14192-14197.
43. Casado M, Bendahan A, Zafra F, Danbolt NC, Aragon C, Gimenez C, Kanner BI. 1993. Phosphorylation and modulation of brain glutamate transporters by protein kinase J Biol Chem 268: 27313-27317.
44. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, et al. 2003. Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science 301: 386-389.
45. Caudle WM, Richardson JR, Wang MZ, Taylor TN, Guillot TS, McCormack AL, Colebrooke RE, Di Monte DA, Emson PC, Miller GW. 2007. Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration. J Neurosci 27: 8138-8148.
46. Cervini R, Houhou L, Pradat PF, Bejanin S, Mallet J, Berrard S. 1995. Specific vesicular acetylcholine transporter promoters lie within the first intron of the rat choline acetyltransferase gene. J Biol Chem 270: 24654-24657.
47. Chanrion B, Mannoury la Cour C, Bertaso F, Lerner-Natoli M, Freissmuth M, Millan MJ, Bockaert J, Marin P. 2007. Physical interaction between the serotonin transporter and neuronal nitric oxide synthase underlies reciprocal modulation of their activity. Proc Natl Acad Sci 104: 8119-8124.
48. Chaudhry FA, Reimer RJ, Krizaj D, Barber D, Storm-Mathisen J, Copenhagen DR, Edwards RH. 1999. Molecular analysis of system N suggests novel physiological roles in nitrogen metabolism and synaptic transmission. Cel 99: 769-780.
49. Chaudhry FA, Reimer RJ, Edwards RH. 2002. The glutamine commute: Take the N line and transfer to the A. J Cell Biol 157: 349-355.
50. Christgau S, Aanstoot HJ, Schierbeck H, Begley K, Tullin S, Hejnaes K, Baekkeskov S. 1992. Membrane anchoring of the autoantigen GAD65 to microvesicles in pancreatic bcells by palmitoylation in the NH2-terminal domain. J Cell Biol 118: 309-320.
51. Chuhma N, Zhang H, Masson J, Zhuang X, Sulzer D, Hen R, Rayport S. 2004. Dopamine neurons mediate a fast excitatory signal via their glutamatergic synapses. J Neurosci 24: 972-981.
52. Claxton DP, Quick M, Shi L, de Carvalho FD, Weinstein H, Javitch JA, McHaourab HS. 2010. Ion/substrate-dependent conformational dynamics of a bacterial homolog of neurotransmitter: Sodium symporters. Nat Struct Mol Biol 17: 822-829.
53. Clements JD. 1996. Transmitter timecourse in the synaptic cleft: Its role in central synaptic function. TrendsNeurosci 19: 163-171.
54. Cohen SM, Nadler JV. 1997a. Proline-induced inhibition of glutamate release in hippocampal area CA1. Brain Res 769: 333-339.
55. Cohen SM, Nadler JV. 1997b. Proline-induced potentiation of glutamate transmission. Brain Res 761: 271-282.
56. Condie BG, Bain G, Gottlieb DI, Capecchi MR. 1997. Cleft palate in mice with a targeted mutation in the γ-aminobutyric acid-producing enzyme glutamic acid decarboxylase 67. Proc Natl Acad Sci 94: 11451-11455.
57. Crump FT, Fremeau RT, Craig AM. 1999. Localization ofthe brain-specific high-affinity L-proline transporter in cultured hippocampal neurons: Molecular heterogeneity of synaptic terminals. Mol Cell Neurosci 13: 25-39.
58. Curthoys NP, Watford M. 1995. Regulation of glutaminase activity and glutamine metabolism. Annu Rev Nutr 15: 133-159.
59. Daniels RW, Collins CA, Chen K, Gelfand MV, Featherstone DE, Diantonio A. 2006. A single vesicular glutamate transporter is sufficient to fill a synaptic vesicle. Neuron 49: 11-16.
60. Daws LC, Montanez S, Munn JL, Owens WA, Baganz NL, Boyce-Rustay JM, Millstein RA, Wiedholz LM, Murphy DL, Holmes A. 2006. Ethanol inhibits clearance of brain serotonin by a serotonin transporter-independent mechanism. J Neurosci 26: 6431-6438.
61. DeFelice LJ, Blakely RD. 1996. Pore models for transporters? Biophys J 70: 579-580.
62. De Gois S, Schafer MK, Defamie N, Chen C, Ricci A, Weihe Varoqui H, Erickson JD. 2005. Homeostatic scaling of vesicular glutamate and GABA transporter expression in rat neocortical circuits. J Neurosci 25: 7121-7133.
63. Deken SL, Beckman ML, Boos L, Quick MW. 2000. Transport rates of GABA transporters: Regulation by the N-terminal domain and syntaxin 1A. Nat Neurosci 3: 998-1003.
64. Dobransky T, Rylett RJ. 2005. A model for dynamic regulation of choline acetyltransferase by phosphorylation. JNeurochem 95: 305-313.
65. Duerr JS, Frisby DL, Gaskin J, Duke A, Asermely K, Huddleston D, Eiden LE, Rand JB. 1999. The cat-1 gene of Caenorhabditis elegans encodes a vesicular monoamine transporter required for specific monoamine-dependent behaviors. J Neurosci 19: 72-84.
66. Erickson JD, Eiden LE, Hoffman BJ. 1992. Expression cloning of a reserpine-sensitive vesicular monoamine transporter. Proc Natl Acad Sci 89: 10993-10997.
67. Erickson JD, Varoqui H, Schafer MD, Modi W, Diebler MF, Weihe E, Rand J, Eiden LE, Bonner TI, Usdin TB. 1994. Functional identification of a vesicular acetylcholine transporter and its expression from a "cholinergic" gene locus. J Biol Chem 269: 21929-21932.
68. Erickson JD, Schafer MK-H, Bonner TI, Eiden LE, Weihe E. 1996. Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. Proc Natl Acad Sci 93: 5166-5171.
69. Falkenburger BH, Barstow KL, Mintz IM. 2001. Dendrodendritic inhibition through reversal ofdopamine transport. Science 293: 2465-2470.
70. Farnsworth SJ, Volz TJ, Hanson GR, Fleckenstein AE. 2009. Cocaine alters vesicular dopamine sequestration and potassium-stimulated dopamine release: The role of D2 receptor activation. J Pharmacol Exp Ther 328: 807-812.
71. Ferguson SM, Savchenko V, Apparsundaram S, Zwick M, Wright J, Heilman CJ, Yi H, Levey AI, Blakely RD. 2003. Vesicular localization and activity-dependent trafficking of presynaptic choline transporters. J Neurosci 23: 9697-9709.
72. Ferguson SM, Bazalakova M, Savchenko V, Tapia JC, Wright J, Blakely RD. 2004. Lethal impairment of cholinergic neurotransmission in hemicholinium-3-sensitive choline transporter knockout mice. Proc Natl Acad Sci 101: 8762-8767.
73. Fleckenstein AE, Hanson GR. 2003. Impact ofpsychostimulants on vesicular monoamine transporter function. Eur J Pharmacol 479: 283-289.
74. Fog JU, Khoshbouei H, Holy M, Owens WA, Vaegter CB, Sen N, Nikandrova Y, Bowton E, McMahon DG, Colbran RJ, et al. 2006. Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport. Neuron 51: 417-429.
75. Fon EA, Pothos EN, Sun BC, Killeen N, Sulzer D, Edwards RH. 1997. Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action. Neuron 19: 1271-1283.
76. Forgac M. 2007. Vacuolar ATPases: Rotary proton pumps in physiology and pathophysiology. Nat Rev Mol Cell Biol 8: 917-929.
77. Fortin GD, Desrosiers CC, Yamaguchi N, Trudeau LE. 2006. Basal somatodendritic dopamine release requires snare proteins. JNeurochem 96: 1740-1749.
78. Foster JD, Pananusorn B, Vaughan RA. 2002. Dopamine transporters are phosphorylated on N-terminal serines in rat striatum. j Biol Chem 277: 25178-25186.
79. Fremeau RT Jr, Caron MG, Blakely RD. 1992. Molecular cloning and expression of a high affinity L-proline transporter expressed in putative glutamatergic pathways of rat brain. Neuron 8: 915-926.
80. Fremeau RT Jr, Burman J, Qureshi T, Tran CH, Proctor J, Johnson J, Zhang H, Sulzer D, Copenhagen DR, Storm-Mathisen J, et al. 2002. The identification ofvesicular glutamate transporter 3 suggests novel modes of signaling by glutamate. Proc Natl Acad Sci 99: 14488-14493.
81. Fremeau RT Jr, Kam K, Qureshi T, Johnson J, Copenhagen DR, Storm-Mathisen J, Chaudhry FA, Nicoll RA, Edwards RH. 2004. Vesicular glutamate transporters 1 and 2 target to functionally distinct synaptic release sites. Science 304: 1815-1819.
82. Fuller RW, Wong DT 1990. Serotonin uptake and serotonin uptake inhibition. Ann NYAcad Sci 600: 68-78.
83. Galli A, Blakely RD, DeFelice LJ. 1996. Norepinephrine transporters have channel modes of conduction. Proc Natl Acad Sci 93: 8671-8676.
84. Galli A, Blakely RD, DeFelice LJ. 1998. Patch-clamp and amperometric recordings from norepinephrine transporters: Channel activity and voltage-dependent uptake. Proc Natl Acad Sci 95: 13260-13265.
85. Gillespie DC, Kim G, Kandler K. 2005. Inhibitory synapses in the developing auditory system are glutamatergic. Nat Neurosci 8: 332-338.
86. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG. 1996. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379: 606-612.
87. Glatt CE, DeYoung JA, Delgado S, Service SK, Giacomini KM, Edwards RH, Risch N, Freimer NB. 2001. Screening a large reference sample to identifyverylowfrequencysequence variants: Comparisons between two genes. Nat Genet 27: 435-438.
88. Glowinski J, Axelrod J. 1964. Inhibition of uptake of tritiated-noradrenaline in the intact rat brain by imipramine and structurally related compounds. Nature 204: 1318-1319.
89. 2+ regulates amphetamine-induced dopamine effiux and currents mediated by the human dopamine transporter. Mol Pharmacol 66: 137-143.
90. Gomeza J, Hulsmann S, Ohno K, Eulenburg V, Szoke K, Richter D, Betz H. 2003a. Inactivation of the glycine transporter 1 gene discloses vital role of glial glycine uptake in glycinergic inhibition. Neuron 40: 785-796.
91. Gomeza J, Ohno K, Hulsmann S, Armsen W, Eulenburg V, Richter DW, Laube B, Betz H. 2003b. Deletion of the mouse glycine transporter 2 results in a hyperekplexia phenotype and postnatal lethality. Neuron 40: 797-806.
92. Gonzalez MI, Bannerman PG, Robinson MB. 2003. Phorbol myristate acetate-dependent interaction ofprotein kinase Ca and the neuronal glutamate transporter EAAC1. J Neurosci 23: 5589-5593.
93. Gorentla BK, Moritz AE, Foster JD, Vaughan RA. 2009. Proline-directed phosphorylation of the dopamine transporter N-terminal domain. Biochemistry 48: 1067-1076.
94. Granas C, Ferrer J, Loland CJ, Javitch JA, Gether U. 2003. N-terminal truncationofthe dopamine transporter abolishes phorbol ester- and substance P receptor-stimulated phosphorylation without impairing transporter internalization. J Biol Chem 278: 4990-5000.
95. Gras C, Herzog E, Bellenchi GC, Bernard V, Ravassard P, Pohl M, Gasnier B, Giros B, El Mestikawy S. 2002. A third vesicular glutamate transporter expressed by cholinergic and serotoninergic neurons. J Neurosci 22: 5442-5451.
96. Gras C, Amilhon B, Lepicard EM, Poirel O, Vinatier j, Herbin M, Dumas S, Tzavara ET, Wade MR, Nomikos GG, et al. 2008. The vesicular glutamate transporter VGLUT3 synergizes striatal acetylcholine tone. Nat Neurosci 11: 292-300.
97. Gresch PJ, Sved AF, Zigmond MJ, Finlay JM. 1995. Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex. J Neurochem 65: 111-116.
98. Gronborg M, Pavlos NJ, Brunk I, Chua JJ, Munster-Wandowski A, Riedel D, Ahnert-Hilger G, Urlaub H, Jahn R. 2010. Quantitative comparison of glutamatergic and GABAergic synaptic vesicles unveils selectivity for few proteins including MAL2, a novel synaptic vesicle protein. JNeurosci 30: 2-12.
99. Grunhage F, Schulze TG, Muller DJ, Lanczik M, Franzek E, Albus M, Borrmann-Hassenbach M, Knapp M, Cichon S, Maier W, et al. 2000. Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1). Mol Psychiatry 5: 275-282.
100. Guastella J, Nelson N, Nelson H, Czyzyk L, Keynan S, Miedel MC, Davidson N, Lester HA, Kanner BI. 1990. Cloning and expression of a rat brain GABA transporter. Science.249: 1303-1306.
101. Gundersen V, Shupliakov O, Brodin L, Ottersen OP, Storm-Mathisen J. 1995. Quantification of excitatory amino acid uptake at intact glutamatergic synapses by immunocyto-chemistry of exogenous D-aspartate. J Neurosci 15:4417-4428.
102. Hahn MK, Robertson D, Blakely RD. 2003. A mutation in the human norepinephrine transporter gene (SLC6A2) associated with orthostatic intolerance disrupts surface expression of mutant and wild-type transporters. JNeurosci 23: 4470-4478.
103. Harkany T, Holmgren C, Hartig W, Qureshi T, Chaudhry FA, Storm-Mathisen J, Dobszay MB, Berghuis P, Schulte G, Sousa KM, et al. 2004. Endocannabinoid-independent retrograde signaling at inhibitory synapses in layer 2/3 of neocortex: Involvement of vesicular glutamate transporter 3. JNeurosci 24: 4978-4988.
104. Hartinger J, Jahn R. 1993. An anion binding site that regulates the glutamate transporter of synaptic vesicles. JBiol Chem 268: 23122-23127.
105. Hashimoto K. 2010. Glycine transport inhibitors for the treatment of schizophrenia. Open Med Chem J 4: 10-19.
106. Haussinger D, Schliess F. 2007. Glutamine metabolism and signaling in the liver. FrontBiosci 12: 371-391.
107. Hell JW, Maycox PR, Jahn R. 1990. Energy dependence and functional reconstitution of the γ-aminobutyric acid carrier from synaptic vesicles. J Biol Chem 265: 2111-2117.
108. 3H-norepinephrine. J Pharm Exp Ther 134: 146-153.
109. Hiesinger PR, Fayyazuddin A, Mehta SQ, Rosenmund T, Schulze KL, zhai RG, Verstreken P, Cao Y, Zhou Y, Kunz J, et al. 2005. The v-ATPase V0 subunit a1 is required for a late step in synaptic vesicle exocytosis in Drosophila. Cell 121: 607-620.
110. Hnasko TS, Chuhma N, Zhang H, Goh GY, Sulzer D, Palmiter RD, Rayport S, Edwards RH. 2010. Vesicular glutamate transport promotes dopamine storage and glutamate corelease in vivo. Neuron 65: 643-656.
111. Holtje M, Winter S, Walther D, Pahner I, Hortnagl H, Ottersen OP, Bader M, Ahnert-Hilger G. 2003. The vesicular monoamine content regulates VMAT2 activity through Galphaq in mouse platelets. Evidence for autoregulation of vesicular transmitter uptake. J Biol Chem 278:15850-15858.
112. Horiuchi M, Nicke A, Gomeza J, Aschrafi A, Schmalzing G, Betz H. 2001. Surface-localized glycine transporters 1 and 2 function as monomeric proteins in Xenopus oocytes. Proc Natl Acad Sci 98: 1448-1453.
113. Ingram SL, Prasad BM, Amara SG. 2002. Dopamine transporter-mediated conductances increase excitability of midbrain dopamine neurons. Nat Neurosci 5: 971-978.
114. Ishikawa T, Sahara Y, Takahashi T. 2002. A single packet of transmitter does not saturate postsynaptic glutamate receptors. Neuron 34: 613-621.
115. Jacob G, Robertson RM, Costa F, Wathen MS, Stein M, Black BK, Biaggioni I, Robertson D. 1997. The local norepinephrine spillover in arms and legs of patients with idiopathic orthostatic intolerance: Evidence of partial dysautonomia. In VIII International Symposium on the Autonomic Nervous System, p. 235. Rapid Science Publishers, London.
116. Jen JC, Wan J, Palos TP, Howard BD, Baloh RW. 2005. Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, seizures. Neurology 65: 529-534.
117. Johnson RG, Carty SE, Scarpa A. 1981. Proton: Substrate stoichiometries during active transport of biogenic amines in chromaffin ghosts. J Biol Chem 256: 5773-5780.
118. Jones SR, Gainetdinov RR, Wightman RM, Caron MG. 1998. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci 18: 1979-1986.
119. Juge N, Yoshida Y, Yatsushiro S, Omote H, Moriyama Y. 2006. Vesicular glutamate transporter contains two independent transport machineries. J Biol Chem 281: 39499-39506.
120. Juge N, Muroyama A, Hiasa M, Omote H, Moriyama Y. 2009. Vesicular inhibitory amino acid transporter is a Cl-/g-aminobutyrate co-transporter. J Biol Chem 284: 35073-35078.
121. Juge N, Gray JA, Omote H, Miyaji T, Hara C, Uneyama H, Edwards RH, Nicoll RA, Moriyama Y 2010. Metabolic control of vesicular glutamate transport and release. Neuron 68: 99-112.
122. Kalandadze A, Wu Y, Robinson MB. 2002. Protein kinase C activation decreases cell surface expression of the GLT-1 subtype of glutamate transporter. Requirement of a carboxyl-terminal domain and partial dependence on serine 486. J Biol Chem 277: 45741-45750.
123. Kam K, Nicoll R. 2007. Excitatory synaptic transmission persists independently of the glutamate-glutamine cycle. J Neurosci 27: 9192-9200.
124. Kaneda N, Sasaoka T, Kobayashi K, Kiuchi K, Nagatsu I, Kurosawa Y, Fujita K, Yokoyama M, Nomura T, Katsuki M, et al. 1991. Tissue-specific and high-level expression of the human tyrosine hydroxylase gene in transgenic mice. Neuron 6: 583-594.
125. Katz B. 1971. Quantal mechanism of neural transmitter release. Science 173: 123-126.
126. Kilic F, Murphy DL, Rudnick G. 2003. A human serotonin transporter mutation causes constitutive activation of transport activity. Mol Pharmacol 64: 440-446.
127. Kilty JE, Lorang D, Amara SG. 1991. Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science 254: 578-580.
128. Kim DK, Lim SW, Lee S, Sohn SE, Kim S, Hahn CG, Carroll BJ. 2000. Serotonin transporter gene polymorphism and antidepressant response. Neuroreport 11: 215-219.
129. Kim CH, Hahn MK, Joung Y, Anderson SL, Steele AH, Mazei-Robinson MS, Gizer I, Teicher MH, Cohen BM, Robertson D, et al. 2006. A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder. Proc Natl Acad Sci 103: 19164-19169.
130. Kish PE, Fischer-Bovenkerk C, Ueda T. 1989. Active transport of γ-aminobutyric acid and glycine into synaptic vesicles. Proc Natl Acad Sci 86: 3877-3881.
131. Klassen LJ, Katzman MA, Chokka P. 2010. Adult ADHD and its comorbidities, with a focus on bipolar disorder. J Affect Disord 124: 1-8.
132. +- linked dopamine transport in chromaffin granule ghosts. Biochemistry 20: 6625-6629.
133. Kohli U, Hahn MK, English BA, Sofowora GG, Muszkat M, Li C, Blakely RD, Stein CM, Kurnik D. 2011. Genetic variation in the presynaptic norepinephrine transporter is associated with blood pressure responses to exercise in healthy humans. Pharmacogenet Genomics 21: 171-178.
134. Krishnamurthy H, Piscitelli CL, Gouaux E. 2009. Unlocking the molecular secrets of sodium-coupled transporters. Nature 459: 347-355.
135. Lambert JJ, Delelli D, Hill-Venning C, Peters JA. 1995. Neurosteroids and GABAA receptor function. Trends Pharm Sc 16: 295-303.
136. Lambert E, Eikelis N, Esler M, Dawood T, Schlaich M, Bayles R, Socratous F, Agrotis A, Jennings G, Lambert G, et al. 2008. Altered sympathetic nervous reactivity and norepinephrine transporter expression in patients with postural tachycardia syndrome. Circ Arrhythm Electrophysiol 1: 103-109.
137. Lee RY, Sawin ER, Chalfie M, Horvitz HR, Avery L. 1999. EAT-4, a homolog of a mammalian sodium-dependent inorganic phosphate cotransporter, is necessary for glutamatergic neurotransmission in caenorhabditis elegans. j Neurosci 19: 159-167.
138. Lee FJ, Pei L, Moszczynska A, Vukusic B, Fletcher PJ, Liu F. 2007. Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor. EMBO j 26: 2127-2136.
139. Lee S, Kim K, Zhou ZJ. 2010. Role of ACh-GABA cotransmission in detecting image motion and motion direction. Neuron 68: 1159-1172.
140. Leo S, Moechars D, Callaerts-Vegh Z, D'Hooge R, Meert T. 2009. Impairment of VGLUT2 but not VGLUT1 signaling reduces neuropathy-induced hypersensitivity. Eur J Pain 13: 1008-1017.
141. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL. 1996. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274: 1527-1531.
142. Lima Rde F, Prado VF, Prado MA, Kushmerick C. 2010. Quantal release ofacetylcholine in mice with reduced levels of the vesicular acetylcholine transporter. JNeurochem 113: 943-951.
143. + toxicity encodes a vesicular amine transporter. Cell 70: 539-551.
144. Macintosh FC, Birks RI, Sastry PB. 1956. Pharmacological inhibition of acetylcholine sythesis. Nature 4543: 1181-1182.
145. Madsen KK, White HS, Schousboe A. 2010. Neuronal and non-neuronal GABA transporters as targets for antiepileptic drugs. Pharmacol Ther 125: 394-401.
146. Mainen ZF, Malinow R, Svoboda K. 1999. Synaptic calcium transients in single spines indicate that NMDA receptors are not saturated. Nature 399: 151-155.
147. Maire JC, Wurtman RJ. 1985. Effects of electrical stimulation and choline availability on the release and contents of acetylcholine and choline in superfused slices from rat striatum. j Physiol (Paris) 80: 189-195.
148. Masson J, Darmon M, Conjard A, Chuhma N, Ropert N, Thoby-Brisson M, Foutz AS, Parrot S, Miller GM, Jorisch R, et al. 2006. Mice lacking brain/kidney phosphate-activated glutaminase have impaired glutamatergic synaptic transmission, altered breathing, disorganized goal-directed behavior and die shortly afier birth. J Neurosci 26: 4660-4671.
149. Mazei-Robison MS, Blakely RD. 2005. Expression studies of naturally occurring human dopamine transporter variants identifies a novel state oftransporter inactivation associated with Val382Ala. Neuropharmacology 49: 737-749.
150. Mazei-Robison MS, Bowton E, Holy M, Schmudermaier M, Freissmuth M, Sitte HH, Galli A, Blakely RD. 2008. Anomalous dopamine release associated with a human dopamine transporter coding variant. J Neurosci 28: 7040-7046.
151. McAllister AK, Stevens CF. 2000. Nonsaturation of AMPA and NMDA receptors at hippocampal synapses. Proc Natl Acad Sci 97: 6173-6178.
152. McDonald PW, Hardie SL, Jessen TN, Carvelli L, Matthies DS, Blakely RD. 2007. Vigorous motor activity in Caenorhabditis elegans requires efficient clearance of dopamine mediated by synaptic localization of the dopamine transporter DAT-1. J Neurosci 27: 14216-14227.
153. McIntire S, Jorgensen E, Horvitz HR. 1993. Genes required for GABA function in Caenorhabditis elegans. Nature 364: 337-341.
154. McIntire SL, Reimer RJ, Schuske K, Edwards RH, Jorgensen EM. 1997. Identification and characterization of the vesicular GABA transporter. Nature 389: 870-876.
155. Miyaji T, Echigo N, Hiasa M, Senoh S, Omote H, Moriyama Y 2008. Identification of a vesicular aspartate transporter. Proc Natl Acad Sci 105: 11720-11724.
156. Morin P, Sagne C, Gasnier B. 2004. Functional characterization of wild-type and mutant human sialin. Embo J 23: 4560-4570.
157. Mosharov EV, Gong LW, Khanna B, Sulzer D, Lindau M. 2003. Intracellular patch electrochemistry: Regulation ofcytosolic catecholamines in chromaffin cells. J Neurosci 23: 5835-5845.
158. Mosharov EV, Larsen KE, Kanter E, Phillips KA, Wilson K, et al. 2009. Interplay between cytosolic dopamine, calcium, and a-synuclein causes selective death of substantia nigra neurons. Neuron 62: 218-229.
159. Murphy DL, Lesch KP. 2008. Targeting the murine serotonin transporter: Insights into human neurobiology. Nat Rev Neurosci 9: 85-96.
160. Nadler JV. 1987. Sodium-dependent proline uptake in the rat hippocampal formation: Association with ipsilateralcommissural projections of CA3 pyramidal cells. JNeurochem 49: 1155-1160.
161. Nakata K, Okuda T, Misawa H. 2004. Ultrastructural localization of high-affinity choline transporter in the rat neuromuscular junction: Enrichment on synaptic vesicles. Synapse 53: 53-56.
162. + dependent inorganic phosphate cotransporter. Proc Natl Acad Sci 91: 5607-5611.
163. Noh J, Seal RP, Garver JA, Edwards RH, Kandler K. 2010. Glutamate co-release at GABA/glycinergic synapses is crucial for the refinement of an inhibitory map. NatNeurosci 13: 232-238.
164. Novarino G, Weinert S, Rickheit G, Jentsch TJ. 2010. Endosomal chloride-proton exchange rather than chloride conductance is crucial for renal endocytosis. Science 328: 1398-1401.
165. Ozaki N, Goldman D, Kaye WH, Plotnicov K, Greenberg BD, Lappalainen J, Rudnick G, Murphy DL. 2003. Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype. Mol Psychiatry 8: 895, 933-896.
166. Pacholczyk T, Blakely RD, Amara SG. 1991. Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 350: 350-354.
167. Parsons SM. 2000. Transport mechanisms in acetylcholine and monoamine storage. FASEB J 14: 2423-2434.
168. Parsons RL, Calupca MA, Merriam LA, Prior C. 1999. Empty synaptic vesicles recycle and undergo exocytosis at vesamicol-treated motor nerve terminals. J Neurophysiol 81: 2696-2700.
169. Pastuszko A, Wilson DF, Erecinska M. 1982. Energetics of g-aminobutyrate transport in rat brain synaptosomes. J Biol Chem 257: 7514-7519.
170. Peter D, Jimenez J, Liu Y, Kim J, Edwards RH. 1994. The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors. J Biol Chem 269: 7231-7237.
171. Peter D, Liu Y, Sternini C, de Giorgio R, Brecha N, Edwards RH. 1995. Differential expression of two vesicular monoamine transporters. J Neurosci 15: 6179-6188.
172. Picollo A, Pusch M. 2005. Chloride/proton antiporter activity of mammalian CLC proteins ClC-4 and ClC-5. Nature 436: 420-423.
173. Pines G, Danbolt NC, Bjoras M, Zhang Y, Bendahan A, Eide L, Koepsell H, Storm-Mathisen J, Seeberg E, Kanner BI. 1992. Cloning and expression of a rat brain L-glutamate transporter. Nature 360: 464-467.
174. Pollock BG, Ferrell RE, Mulsant BH, Mazumdar S, Miller M, Sweet RA, Davis S, Kirshner MA, Houck PR, Stack JA, et al. 2000. Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression. Neuropsychopharmacology 23: 587-590.
175. Pow DV, Robinson SR. 1994. Glutamate in some retinal neurons is derived solely from glia. Neuroscience 60: 355-366.
176. Prasad HC, Zhu CB, McCauley JL, Samuvel DJ, Ramamoorthy S, Shelton RC, Hewlett WA, Sutcliffe JS, Blakely RD. 2005. Human serotonin transporter variants display altered sensitivity to protein kinase G and 38 mitogen-activated protein kinase. Proc Natl Acad Sci 102: 11545-11550.
177. Prasad HC, Steiner JA, Sutcliffe JS, Blakely RD. 2009. Enhanced activity of human serotonin transporter variants associated with autism. Philos Trans R Soc Lond B Biol Sci 364: 163-173.
178. Price GD, Trussell LO. 2006. Estimate of the chloride concentration in a central glutamatergic terminal: A gramicidin perforated-patch study on the calyx of Held. JNeurosci 26: 11432-11436.
179. Quick MW. 2003. Regulating the conducting states of mammalian serotonin transporter. Neuron 40: 537-549.
180. Quick MW, Corey JL, Davidson N, Lester HA. 1997. Second messengers, trafficking-related proteins, and amino acid residues that contribute to the functional regulation of the rat brain GABA transporter GAT1. J Neurosci 17: 2967-2979.
181. Raj V, Haman KL, Raj SR, Byrne D, Blakely RD, Biaggioni I, Robertson D, Shelton RC. 2009. Psychiatric profile and attention deficits in postural tachycardia syndrome. J Neurol Neurosurg Psychiatry 80: 339-344.
182. Ramamoorthy S, Blakely RD. 1999. Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Science 285: 763-766.
183. Ramamoorthy S, Giovanetti E, Qian Y, Blakely RD. 1998. Phosphorylation and regulation of antidepressant-sensitive serotonin transporters. J Biol Chem 273: 2458-2466.
184. Ramamoorthy S, Samuvel DJ, Buck ER, Rudnick G, Jayanthi LD. 2007. Phosphorylation ofthreonine residue 276 is required for acute regulation of serotonin transporter by cyclic GMP J Biol Chem 282: 11639-11647.
185. Ramamoorthy S, Shippenberg TS, Jayanthi LD. 2011. Regulation of monoamine transporters: Role of transporter phosphorylation. Pharmacol Ther 129: 220-238.
186. Ren J, Qin C, Hu F, Tan J, Qiu L, Zhao S, Feng G, Luo M. 2011. Habenula "cholinergic" neurons corelease glutamate and acetylcholine and activate postsynaptic neurons via distinct transmission modes. Neuron 69: 445-452.
187. Renick SE, Kleven DT, Chan J, Stenius K, Milner TA, Pickel VM, Fremeau RT Jr. 1999. The mammalian brain high- affinity L-proline transporter is enriched preferentially in synaptic vesicles in a subpopulation ofexcitatorynerve terminals in rat forebrain. J Neurosci 19: 21-33.
188. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, Kanai Y, Hediger MA, Wang YF, Schielke JP, et al. 1996. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16: 675-686.
189. Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang YH, Bergles DE, Jin L, Dykes Hoberg M, Vidensky S, Chung DS, et al. 2005. b-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433: 73-77.
190. Rudnick G. 1997. Mechanisms of biogenic amine neurotransmitter transporters. In Neurotransmitter transporters: Structure, function, and regulation (ed. Reith MEA), pp. 73-100. Humana Press, Totowa, NJ.
191. Rudnick G, Wall SC. 1992. The molecular mechanism of"ecstasy" [3,4-methylenedioxymethamphetamine (MDMA)]: Serotonin transporters are targets for MDMA-induced serotonin release. Proc Natl Acad Sci 89: 1817-1821.
192. Samuvel DJ, Jayanthi LD, Bhat NR, Ramamoorthy S. 2005. A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: Evidence for distinct cellular mechanisms involved in transporter surface expression. J Neurosci 25: 29-41.
193. Sarter M, Parikh V. 2005. Choline transporters, cholinergic transmission and cognition. Nat Rev Neurosci 6: 48-56.
194. Sawada K, Echigo N, Juge N, Miyaji T, Otsuka M, Omote H, Yamamoto A, Moriyama Y. 2008. Identification of a vesicular nucleotide transporter. Proc Natl Acad Sci 105: 5683-5686.
195. Schafer MK, Varoqui H, Defamie N, Weihe E, Erickson JD. 2002. Molecular cloning and functional identification of mouse vesicular glutamate transporter 3 and its expression in subsets of novel excitatory neurons. J Biol Chem 277: 50734-50748.
196. Schallier A, Massie A, Loyens E, Moechars D, Drinkenburg W, Michotte Y, Smolders I. 2009. vGLUT2 heterozygous mice show more susceptibility to clonic seizures induced by pentylenetetrazol. Neurochem Int 55: 41-44.
197. Scheel O, Zdebik AA, Lourdel S, Jentsch TJ. 2005. Voltage- dependent electrogenic chloride/proton exchange by endosomal CLC proteins. Nature 436: 424-427.
198. Schenck S, Wojcik SM, Brose N, Takamori S. 2009. A chloride conductance in VGLUT1 underlies maximal glutamate loading into synaptic vesicles. Nat Neurosci 12: 156-162.
199. Schuske K, Palfreyman MT, Watanabe S, Jorgensen EM. 2007. UNC-46 is required for trafficking of the vesicular GABA transporter. Nat Neurosci 10: 846-853.
200. Seal RP, Akil O, Yi E, Weber CM, Grant L, Yoo J, Clause A, Kandler K, Noebels JL, Glowatzki E, et al. 2008. Sensorineural deafness and seizures in mice lacking vesicular glutamate transporter 3. Neuron 57: 263-275.
201. Shannon JR, Flattem NL, Jordan J, Jacob G, Black BK, Biaggioni I, Blakely RD, Robertson D. 2000. Orthostatic intolerance and tachycardia associated with norepinephrinetransporter deficiency. NEngl J Med 342: 541-549.
202. Sinning S, Musgaard M, Jensen M, Severinsen K, Celik L, Koldso H, Meyer T, Bols M, Jensen HH, Schiott B, et al. 2010. Binding and orientation oftricyclic antidepressants within the central substrate site of the human serotonin transporter. J Biol Chem 285: 8363-8374.
203. Song H, Ming G, Fon E, Bellocchio E, Edwards RH, Poo M. 1997. Expression of a putative vesicular acetylcholine transporter facilitates quantal transmitter packaging. Neuron 18: 815-826.
204. Steiner JA, Carneiro AM, Blakely RD. 2008. Going with the flow: Trafficking-dependent and -independent regulation of serotonin transport. Traffic 9: 1393-1402.
205. Stobrawa SM, Breiderhoff T, Takamori S, Engel D, Schweizer M, Zdebik AA, Bosl MR, Ruether K, Jahn H, Draguhn A, et al. 2001. Disruption of ClC-3, a chloride channel expressed on synaptic vesicles, leads to a loss ofthe hippocampus. Neuron 29: 185-196.
206. Storm-Mathisen J, Leknes AK, Bore AT, Vaaland JL, Edminson P, Haug FM, Ottersen OP. 1983. First visualization of glutamate and GABA in neurones by immunocytochemistry. Nature 301: 517-520.
207. Stuber GD, Hnasko TS, Britt JP, Edwards RH, Bonci A. 2010. Dopaminergic terminals in the nucleus accumbens but not the dorsal striatum corelease glutamate. J Neurosci 30: 8229-8233.
208. Su A, Mager S, Mayo SL, Lester HA. 1996. A multi-substrate single-file model for ion-coupled transporters. Biophys J 70: 762-777.
209. Sulzer D, Maidment NT, Rayport S. 1993. Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. J Neurochem 60: 527-535.
210. Sung U, Apparsundaram S, Galli A, Kahlig KM, Savchenko V, Schroeter S, Quick MW, Blakely RD. 2003. A regulated interaction of syntaxin 1A with the antidepressant-sensitive norepinephrine transporter establishes catecholamine clearance capacity. J Neurosci 23: 1697-1709.
211. Sutcliffe JS, Delahanty RJ, Prasad HC, McCauley JL, Han Q, Jiang L, Li C, Folstein SE, Blakely RD. 2005. Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. Am J Hum Genet 77: 265-279.
212. Takahashi N, Miner LL, Sora I, Ujike H, Revay RS, Kostic V, Jackson-Lewis V, Przedborski S, Uhl GR. 1997. VMAT2 knockout mice: Heterozygous display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion and enhanced MPTP toxicity. Proc Natl Acad Sci 94: 9938-9943.
213. Takamori S, Rhee JS, Rosenmund C, Jahn R. 2000. Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons. Nature 407: 189-194.
214. Tani H, Bandrowski AE, Parada I, Wynn M, Huguenard JR, et al. 2007. Modulation of epileptiform activity by glutamine and system A transport in a model of posttraumatic epilepsy. Neurobiol Dis 25: 230-238.
215. Tecuapetla F, Patel JC, Xenias H, English D, Tadros I, Shah F, Berlin J, Deisseroth K, Rice ME, Tepper JM, et al. 2010. Glutamatergic signaling by mesolimbic dopamine neurons in the nucleus accumbens. J Neurosci 30: 7105-7110.
216. Tian N, Petersen C, Kash S, Baekkeskov S, Copenhagen D, Nicoll R. 1999. The role of the synthetic enzyme GAD65 in the control of neuronal γ-aminobutyric acid release. Proc Natl Acad Sci 96: 12911-12916.
217. Torres GE, Yao WD, Mohn RR, Quan H, Kim K, Levey AI, Staudinger J, Caron MG. 2001. Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1. Neuron 30: 121-134.
218. Torres GE, Carneiro A, Seamans K, Fiorentini C, Sweeney A, Yao WD, Caron MG. 2003a. Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter. J Biol Chem 278: 2731-2739.
219. Torres GE, Gainetdinov RR, Caron MG. 2003b. Plasma membrane monoamine transporters: Structure, regulation and function. Nat Rev Neurosci 4: 13-25.
220. Van der Kloot W 2003. Loading and recycling of synaptic vesicles in the Torpedo electric organ and the vertebrate neuromuscular junction. Prog Neurobiol 71: 269-303.
221. Varga V, Losonczy A, Zemelman BV, Borhegyi Z, Nyiri G, Domonkos A, Hangya B, Holderith N, Magee JC, Freund TF. 2009. Fast synaptic subcortical control ofhippocampal circuits. Science 326: 449-453.
222. Varoqui H, Erickson JD. 1996. Active transport of acetylcholine by the human vesicular acetylcholine transporter. J Biol Chem 271: 27229-27232.
223. Vaughan RA, Huff RA, Uhl RR, Kuhar MJ. 1997. Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes. J Biol Chem 272: 15541-15546.
224. Verheijen FW, Verbeek E, Aula N, Beerens CE, Havelaar AC, Joosse M, Peltonen L, Aula P, Galjaard H, van der Spek PJ, et al. 1999. A new gene, encoding an anion transporter, is mutated in sialic acid storage diseases. Nature Genet 23: 462-465.
225. Voglmaier SM, Kam K, Yang H, Fortin DL, Hua Z, Nicoll RA, Edwards RH. 2006. Distinct endocytic pathways control the rate and extent of synaptic vesicle protein recycling. Neuron 51: 71-84.
226. Volz TJ, Farnsworth SJ, King JL, Riddle EL, Hanson GR, Fleckenstein AE. 2007. Methylphenidate administration alters vesicular monoamine transporter-2 function in cytoplasmic and membrane-associated vesicles. J Pharmacol Exp Ther 323: 738-745.
227. Wallen-Mackenzie A, Gezelius H, Thoby-Brisson M, Nygard A, Enjin A, Fujiyama F, Fortin G, Kullander K. 2006. Vesicular glutamate transporter 2 is required for central respiratory rhythm generation but not for locomotor central pattern generation. J Neurosci 26: 12294-12307.
228. Wang YM, Gainetdinov RR, Fumagalli F, Xu F, Jones SR, Bock CB, Miller GW, Wightman RM, Caron MG. 1997. Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine. Neuron 19: 1285-1296.
229. Weihe E, Schafer MK, Erickson JD, Eiden LE. 1994. Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat. J Mol Neurosci 5: 149-164.
230. Weston MC, Nehring RB, Wojcik SM, Rosenmund C. 2011. Interplay between VGLUT isoforms and endophilin A1 regulates neurotransmitter release and short-term plasticity. Neuron 69: 1147-1159.
231. Whitby LG, Hertting G, Axelrod J. 1960. Effect of cocaine on the disposition of noradrenaline labelled with tritium. Nature 187: 604-605.
232. Winter S, Brunk I, Walther DJ, Holtje M, Jiang M, Peter JU, Takamori S, Jahn R, Birnbaumer L, Ahnert-Hilger G. 2005. Go2a regulates vesicular glutamate transporter activity by changing its chloride dependence. J Neurosci 25: 4672-4680.
233. Wojcik SM, Rhee JS, Herzog E, Sigler A, Jahn R, Takamori S, Brose N, Rosenmund C. 2004. An essential role for vesicular glutamate transporter 1 (VGLUT1) in postnatal development and control of quantal size. Proc Natl Acad Sci 101: 7158-7163.
234. Wojcik SM, Katsurabayashi S, Guillemin I, Friauf E, Rosenmund C, Brose N, Rhee JS. 2006. A shared vesicular carrier allows synaptic corelease of GABA and glycine. Neuron 50: 575-587.
235. Wolosker H, de Souza DO, de Meis L. 1996. Regulation of glutamate transport into synaptic vesicles by chloride and proton gradient. J Biol Chem 271: 11726-11731.
236. Wreden CC, Wlizla M, Reimer RJ. 2005. Varied mechanisms underlie the free sialic acid storage disorders. J Biol Chem 280: 1408-1416.
237. Yamamura HI, Snyder SH. 1972. Choline: High-affinity uptake by rat brain synaptosomes. Science 178: 626-628.
238. +/Cl dependent neurotransmitter transporters. Nature 437: 215-223.
239. Yernool D, Boudker O, Folta-Stogniew E, Gouaux E. 2003. Trimeric subunit stoichiometry of the glutamate transporters from Bacillus caldotenax and Bacillus stearothermophilus. Biochemistry 42: 12981-12988.
240. Yernool D, Boudker O, Jin Y, Gouaux E. 2004. Structure ofa glutamate transporter homologue from Pyrococcus horikoshii. Nature 431: 811-818.
241. Zalsman G, Huang YY, Oquendo MA, Burke AK, Hu XZ, Brent DA, Ellis SP, Goldman D, Mann JJ. 2006. Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression. Am J Psychiatry 163: 1588-1593.
242. Zerangue N, Kavanaugh MP. 1996. Flux coupling in a neuronal glutamate transporter. Nature 383: 634-637.
243. Zhao Y, Terry D, Shi L, Weinstein H, Blanchard SC, Javitch JA. 2010. Single-molecule dynamics of gating in a neurotransmitter transporter homologue. Nature 465: 188-193.
244. Zhou Q, Petersen CCH, Nicoll RA. 2000. Effects of reduced vesicular filling on synaptic transmission in rat hippocampal neurones. J Physiol 525: 195-206.
245. Zhou FM, Liang Y, Salas R, Zhang L, De Biasi M, Dani JA. 2005. Corelease ofdopamine and serotonin from striatal dopamine terminals. Neuron 46: 65-74.
246. Zhu C, Hewlett W, Feoktistov I, Biaggioni I, Blakely RD. 2004. Adenosine receptor, protein kinase G, and p38 mitogen-activated protein kinase-dependent up-regulation of serotonin transporters involves both transporter trafficking and activation. Mol Pharmacol 65: 1462-1474.
247. Zhu CB, Carneiro AM, Dostmann WR, Hewlett WA, Blakely RD. 2005. p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process. J Biol Chem 280: 15649-15658.
248. Zhu CB, Steiner JA, Munn JL, Daws LC, Hewlett WA, Blakely RD. 2007. Rapid stimulation of presynaptic serotonin transport by a3 adenosine receptors. J Pharmacol Exp Ther 322: 332-340.
249. Zigmond RE, Schwarzschild MA, Rittenhouse AR. 1989. Acute regulation of tyrosine hydroxylase by nerve activity and by neurotransmitters via phosphorylation. Ann Rev Neurosci 12: 415-461.
250. Zomot E, Bendahan A, Quick M, Zhao Y, Javitch JA, Kanner BI. 2007. Mechanism of chloride interaction with neurotransmitter: Sodium symporters. Nature 449: 726-730.